Mercator Medical S.A. (MRC) - Net Assets
Based on the latest financial reports, Mercator Medical S.A. (MRC) has net assets worth zł890.05 Million PLN (≈ $244.96 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł1.00 Billion ≈ $276.27 Million USD) and total liabilities (zł113.78 Million ≈ $31.31 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Mercator Medical S.A.'s assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł890.05 Million |
| % of Total Assets | 88.67% |
| Annual Growth Rate | 35.25% |
| 5-Year Change | -11.31% |
| 10-Year Change | 1172.53% |
| Growth Volatility | 185.28 |
Mercator Medical S.A. - Net Assets Trend (2012–2024)
This chart illustrates how Mercator Medical S.A.'s net assets have evolved over time, based on quarterly financial data. Also explore Mercator Medical S.A. assets under control for the complete picture of this company's asset base.
Annual Net Assets for Mercator Medical S.A. (2012–2024)
The table below shows the annual net assets of Mercator Medical S.A. from 2012 to 2024. For live valuation and market cap data, see market cap of Mercator Medical S.A..
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | zł925.16 Million ≈ $254.62 Million |
+7.61% |
| 2023-12-31 | zł859.71 Million ≈ $236.60 Million |
-14.81% |
| 2022-12-31 | zł1.01 Billion ≈ $277.75 Million |
-11.87% |
| 2021-12-31 | zł1.15 Billion ≈ $315.18 Million |
+9.78% |
| 2020-12-31 | zł1.04 Billion ≈ $287.09 Million |
+675.80% |
| 2019-12-31 | zł134.46 Million ≈ $37.01 Million |
+0.88% |
| 2018-12-31 | zł133.29 Million ≈ $36.68 Million |
+11.32% |
| 2017-12-31 | zł119.74 Million ≈ $32.95 Million |
-3.01% |
| 2016-12-31 | zł123.46 Million ≈ $33.98 Million |
+69.82% |
| 2015-12-31 | zł72.70 Million ≈ $20.01 Million |
+8.17% |
| 2014-12-31 | zł67.21 Million ≈ $18.50 Million |
+17.65% |
| 2013-12-31 | zł57.13 Million ≈ $15.72 Million |
+131.34% |
| 2012-12-31 | zł24.69 Million ≈ $6.80 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Mercator Medical S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 185235.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | zł895.17 Million | 96.43% |
| Common Stock | zł9.77 Million | 1.05% |
| Other Comprehensive Income | zł-7.36 Million | -0.79% |
| Other Components | zł30.74 Million | 3.31% |
| Total Equity | zł928.32 Million | 100.00% |
Mercator Medical S.A. Competitors by Market Cap
The table below lists competitors of Mercator Medical S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Samyang Packaging
KO:272550
|
$122.08 Million |
|
Marvipol S.A.
WAR:MVP
|
$122.08 Million |
|
Adriano Care SOCIMI SAU
MC:YADR
|
$122.09 Million |
|
Ace Technologies Corp
KQ:088800
|
$122.13 Million |
|
Macpower CNC Machines Limited
NSE:MACPOWER
|
$122.00 Million |
|
Adese Gayrimenkul Yatirim AS
IS:ADESE
|
$121.91 Million |
|
MEDIANA Co.Ltd
KQ:041920
|
$121.88 Million |
|
Korea Air Svc
KO:005430
|
$121.86 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mercator Medical S.A.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 862,087,000 to 928,319,000, a change of 66,232,000 (7.7%).
- Net income of 51,049,000 contributed positively to equity growth.
- Share repurchases of 14,950,000 reduced equity.
- Other comprehensive income increased equity by 26,762,001.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | zł51.05 Million | +5.5% |
| Share Repurchases | zł14.95 Million | -1.61% |
| Other Comprehensive Income | zł26.76 Million | +2.88% |
| Other Changes | zł3.37 Million | +0.36% |
| Total Change | zł- | 7.68% |
Book Value vs Market Value Analysis
This analysis compares Mercator Medical S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.49x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 19.99x to 0.49x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | zł2.43 | zł48.50 | x |
| 2013-12-31 | zł6.22 | zł48.50 | x |
| 2014-12-31 | zł7.78 | zł48.50 | x |
| 2015-12-31 | zł8.35 | zł48.50 | x |
| 2016-12-31 | zł13.19 | zł48.50 | x |
| 2017-12-31 | zł11.17 | zł48.50 | x |
| 2018-12-31 | zł12.50 | zł48.50 | x |
| 2019-12-31 | zł12.57 | zł48.50 | x |
| 2020-12-31 | zł98.76 | zł48.50 | x |
| 2021-12-31 | zł113.01 | zł48.50 | x |
| 2022-12-31 | zł103.24 | zł48.50 | x |
| 2023-12-31 | zł89.95 | zł48.50 | x |
| 2024-12-31 | zł98.87 | zł48.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mercator Medical S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.50%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.41%
- • Asset Turnover: 0.52x
- • Equity Multiplier: 1.12x
- Recent ROE (5.50%) is below the historical average (16.26%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 37.01% | 5.87% | 1.74x | 3.61x | zł5.66 Million |
| 2013 | 12.77% | 4.65% | 1.47x | 1.86x | zł1.49 Million |
| 2014 | 14.91% | 5.95% | 1.19x | 2.11x | zł3.30 Million |
| 2015 | 14.14% | 4.53% | 1.43x | 2.17x | zł3.01 Million |
| 2016 | 11.39% | 5.27% | 1.27x | 1.70x | zł1.70 Million |
| 2017 | 4.17% | 1.64% | 1.04x | 2.44x | zł-6.90 Million |
| 2018 | 5.64% | 1.78% | 1.10x | 2.89x | zł-5.77 Million |
| 2019 | -1.53% | -0.38% | 1.40x | 2.90x | zł-15.34 Million |
| 2020 | 89.44% | 50.71% | 1.42x | 1.24x | zł826.19 Million |
| 2021 | 39.07% | 25.87% | 1.34x | 1.13x | zł332.48 Million |
| 2022 | -18.80% | -34.95% | 0.50x | 1.07x | zł-290.50 Million |
| 2023 | -2.28% | -4.19% | 0.49x | 1.12x | zł-105.88 Million |
| 2024 | 5.50% | 9.41% | 0.52x | 1.12x | zł-41.78 Million |
Industry Comparison
This section compares Mercator Medical S.A.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $-24,319,000
- Average return on equity (ROE) among peers: 0.00%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mercator Medical S.A. (MRC) | zł890.05 Million | 37.01% | 0.13x | $122.06 Million |
| Airway (AWM) | $-24.32 Million | 0.00% | 0.00x | $8.15 Million |
About Mercator Medical S.A.
Mercator Medical S.A., together with its subsidiaries, manufactures and distributes disposable medical gloves, dressings, and non-woven fabric products in Poland, the Czech Republic, Ukraine, France, Hungary, Italy, Romania, Germany, rest of Europe, and Thailand. The company offers surgical and protective, sterile examination and protective, and household gloves; glove brackets; and household and… Read more